中华核医学与分子影像杂志
中華覈醫學與分子影像雜誌
중화핵의학여분자영상잡지
Chinese Journal of Nuclear Medicine and Molecular Imaging
2014年
4期
308-311
,共4页
朱宝%谢国强%肖华龙%黄飚%邵科晶%许亚丰%张艺
硃寶%謝國彊%肖華龍%黃飚%邵科晶%許亞豐%張藝
주보%사국강%초화룡%황표%소과정%허아봉%장예
荧光免疫测定%生物素%抗生蛋白链菌素%乙酰肝素酶
熒光免疫測定%生物素%抗生蛋白鏈菌素%乙酰肝素酶
형광면역측정%생물소%항생단백련균소%을선간소매
Fluoroimmunoassay%Biotin%Streptavidin%Heparanase
目的 建立测定乙酰肝素酶(HPA)的生物素-链亲和素系统(BSA) TRFIA并进行初步应用.方法 采用部分基因重组的鼠抗人HPA单克隆抗体包被微孔板条,加入HPA标准品和生物素标记的HPA,两者竞争性结合HPA单克隆抗体,再利用铕标记链亲和素(Eu3+-SA)作为示踪物,建立竞争法BSA-TRFIA.利用该方法检测健康人血清样本(n=32)和肿瘤患者血清样本(n=54)HPA水平,并比较TRFIA结果与ELISA结果的相关性.数据分析采用两样本t检验或t’检验、直线相关分析.结果 该法测定HPA的灵敏度为0.33 iug/L,批内和批间CV分别为5.29%和7.54%,平均回收率为105.5%,标准曲线范围为O-1 000 txg/L.健康人血清样本测定结果为(2.03±1.47)p.g/L,患者血清样本为(22.13_+7.38) tg/L(t’=19.388.P<O.01).该法测定值与ELISA结果相关(r=0.979,p<0.01).结论 应用BSA-TRFIA建立的HPA测定法是一种灵敏度高,可测范围广,稳定,高效的定量检测方法.
目的 建立測定乙酰肝素酶(HPA)的生物素-鏈親和素繫統(BSA) TRFIA併進行初步應用.方法 採用部分基因重組的鼠抗人HPA單剋隆抗體包被微孔闆條,加入HPA標準品和生物素標記的HPA,兩者競爭性結閤HPA單剋隆抗體,再利用銪標記鏈親和素(Eu3+-SA)作為示蹤物,建立競爭法BSA-TRFIA.利用該方法檢測健康人血清樣本(n=32)和腫瘤患者血清樣本(n=54)HPA水平,併比較TRFIA結果與ELISA結果的相關性.數據分析採用兩樣本t檢驗或t’檢驗、直線相關分析.結果 該法測定HPA的靈敏度為0.33 iug/L,批內和批間CV分彆為5.29%和7.54%,平均迴收率為105.5%,標準麯線範圍為O-1 000 txg/L.健康人血清樣本測定結果為(2.03±1.47)p.g/L,患者血清樣本為(22.13_+7.38) tg/L(t’=19.388.P<O.01).該法測定值與ELISA結果相關(r=0.979,p<0.01).結論 應用BSA-TRFIA建立的HPA測定法是一種靈敏度高,可測範圍廣,穩定,高效的定量檢測方法.
목적 건립측정을선간소매(HPA)적생물소-련친화소계통(BSA) TRFIA병진행초보응용.방법 채용부분기인중조적서항인HPA단극륭항체포피미공판조,가입HPA표준품화생물소표기적HPA,량자경쟁성결합HPA단극륭항체,재이용유표기련친화소(Eu3+-SA)작위시종물,건립경쟁법BSA-TRFIA.이용해방법검측건강인혈청양본(n=32)화종류환자혈청양본(n=54)HPA수평,병비교TRFIA결과여ELISA결과적상관성.수거분석채용량양본t검험혹t’검험、직선상관분석.결과 해법측정HPA적령민도위0.33 iug/L,비내화비간CV분별위5.29%화7.54%,평균회수솔위105.5%,표준곡선범위위O-1 000 txg/L.건강인혈청양본측정결과위(2.03±1.47)p.g/L,환자혈청양본위(22.13_+7.38) tg/L(t’=19.388.P<O.01).해법측정치여ELISA결과상관(r=0.979,p<0.01).결론 응용BSA-TRFIA건립적HPA측정법시일충령민도고,가측범위엄,은정,고효적정량검측방법.
Objective To establish a novel TRFIA for the measurement of heparanase (HPA) in serum samples,and investigate its clinical application.Methods The micro-pore plate wells were first coated with partially recombinant murine anti-human HPA monoclonal antibody.Biotin-labeled recombinant HPA protein was then used to compete with HPA in serum samples,and the prepared europium (III)-labeled streptavidin (Eu3+-SA) was used as signal readout for establishing the BSA-TRFIA assay.Using this assay,the serum HPA levels in healthy subjects (n=32) and tumor patients (n=54) were measured.The results of BSA-TRFIA were compared with those of ELISA.Two-sample t test (or t' test),and linear correlation analysis were used to analyze the data.Results The sensitivity of BSA-TRFIA for measuring HPA was 0.33 ug/L.The CV values for intra-batch and inter-batch were 5.29% and 7.54%,respectively.The average recovery rate was 105.5%.The standard curve range was 0-1 000 ug/L.The serum HPA level measured by the BSA-TRFIA method in healthy subjects was (2.03_+ 1.47) Iug/L.In tumor patients,the HPA level was significantly higher:(22.13_+7.38) ug/L (t'=19.388,P<O.01).The HPA values measured by the BSATRFIA method were in good agreement with those by ELISA method (r=0.979,P<0.01).Conclusion BSA-TRFIA is a highly sensitive and stable method with efficient quantization and wide dynamic range for the measurement of HPA.